Colorectal Cancer 12

Categories: Genetic diseases, Cancer diseases, Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Colorectal Cancer 12

MalaCards integrated aliases for Colorectal Cancer 12:

Name: Colorectal Cancer 12 54 71
Colorectal Cancer, Susceptibility to, 12 29 13
Susceptibility to Colorectal Cancer on Chromosome 12q24 71
Crcs12 71



patients develop multiple tumors
onset before age 40 years
some tumors may be microsatellite instable and carry somatic mutations in msh mismatch repair genes
tumors are microsatellite stable

autosomal dominant


colorectal cancer 12:
Inheritance autosomal dominant inheritance
Onset and clinical course adult onset


External Ids:

OMIM 54 615083
MeSH 42 D015179
SNOMED-CT via HPO 65 263681008 399505005

Summaries for Colorectal Cancer 12

UniProtKB/Swiss-Prot : 71 Colorectal cancer 12: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. CRCS12 is characterized by a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. Onset is usually before age 40 years. The histologic features of the tumors are unremarkable.

MalaCards based summary : Colorectal Cancer 12, also known as colorectal cancer, susceptibility to, 12, is related to colorectal cancer susceptibility 12 and fils syndrome, and has symptoms including colorectal polyposis An important gene associated with Colorectal Cancer 12 is POLE (DNA Polymerase Epsilon, Catalytic Subunit). The drugs Fluorouracil and Oxaliplatin have been mentioned in the context of this disorder. Affiliated tissues include colon, liver and testes.

OMIM : 54
Colorectal cancer-12 is an autosomal dominant disorder characterized by a high-penetrance predisposition to the development of colorectal adenomas and carcinomas, with a variable tendency to develop multiple and large tumors. Onset usually occurs before age 40 years. The histologic features of the tumors may be unremarkable (Palles et al., 2013) or show microsatellite instability (MSI) (Elsayed et al., 2015). For a general phenotypic description and a discussion of genetic heterogeneity of colorectal cancer, see 114500. (615083)

Related Diseases for Colorectal Cancer 12

Symptoms & Phenotypes for Colorectal Cancer 12

Symptoms via clinical synopsis from OMIM:


colorectal carcinoma
endometrial cancer

Abdomen- Gastroin testinal:
colorectal carcinoma
colorectal polyps
colorectal adenomas

Clinical features from OMIM:


Human phenotypes related to Colorectal Cancer 12:

id Description HPO Frequency HPO Source Accession
1 colorectal polyposis 32 HP:0200063

Drugs & Therapeutics for Colorectal Cancer 12

Drugs for Colorectal Cancer 12 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 331)
id Name Status Phase Clinical Trials Cas Number PubChem Id
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61825-94-3 5310940 9887054 43805 6857599
Iron Approved Phase 4,Phase 2 7439-89-6 23925
Erythromycin Approved, Vet_approved Phase 4 114-07-8 12560
Benzocaine Approved Phase 4,Phase 2 1994-09-7, 94-09-7 2337
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 216974-75-3
Capecitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 154361-50-9 60953
Irinotecan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 97682-44-5, 100286-90-6 60838
Heparin Approved, Investigational Phase 4,Phase 2,Phase 3 9005-49-6 772 46507594
Udenafil Approved, Investigational Phase 4 268203-93-6 6918523
Zinc Approved Phase 4 7440-66-6 32051 23994
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 143 6006
13 tannic acid Approved, Nutraceutical Phase 4,Phase 2
Camptothecin Experimental Phase 4,Phase 3,Phase 2,Phase 1 7689-03-4
15 Ferrous fumarate Phase 4
16 Micronutrients Phase 4,Phase 2,Phase 3,Phase 1
17 Trace Elements Phase 4,Phase 2,Phase 3,Phase 1
18 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
19 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
20 Erythromycin Estolate Phase 4
21 Erythromycin Ethylsuccinate Phase 4
22 Erythromycin stearate Phase 4
23 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
24 Angiogenesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
25 Angiogenesis Modulating Agents Phase 4,Phase 3,Phase 2,Phase 1
26 Liver Extracts Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
27 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1
28 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2,Phase 1
29 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2
31 Hormone Antagonists Phase 4,Phase 3,Phase 2
32 Hormones Phase 4,Phase 3,Phase 2
33 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
34 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
35 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1
36 topoisomerase I inhibitors Phase 4,Phase 3,Phase 2,Phase 1
37 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
38 calcium heparin Phase 4,Phase 2,Phase 3
39 Phosphodiesterase 5 Inhibitors Phase 4
40 Phosphodiesterase Inhibitors Phase 4
41 Sildenafil Citrate Phase 4 171599-83-0
42 Vasodilator Agents Phase 4
43 Hypoglycemic Agents Phase 4,Phase 2
44 insulin Phase 4,Phase 2
45 Insulin, Globin Zinc Phase 4,Phase 2
46 Amino-acid, glucose, and electrolyte solution Phase 4
47 Anabolic Agents Phase 4
48 Parenteral Nutrition Solutions Phase 4
49 Cola Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Citrate Nutraceutical Phase 4

Interventional clinical trials:

(show top 50) (show all 500)

id Name Status NCT ID Phase Drugs
1 OPTIMOX1 in Chinese mCRC Patients Unknown status NCT01023633 Phase 4 Oxaliplatin, LV, 5-FU
2 Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia Unknown status NCT02243735 Phase 4 Ferrous fumarate;ferric(III)carboxymaltose
3 Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis Unknown status NCT02175914 Phase 4 Erythromycin
4 Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles Completed NCT00868816 Phase 4 12 cycles of oxaliplatine based adjuvant chemotherapy;8 cycles of oxaliplatine based adjuvant chemotherapy
5 A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer Completed NCT01695772 Phase 4 5-FU based doublet chemotherapy;bevacizumab
6 Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer Completed NCT02284529 Phase 4 Orectalip
7 Dissemination of Colorectal Cancer Screening to Primary Care Physicians Completed NCT00441311 Phase 4
8 A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer Completed NCT02567331 Phase 4 Capecitabine
9 Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients Completed NCT01732783 Phase 4
10 Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients Completed NCT01641458 Phase 4
11 A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. Completed NCT00502671 Phase 4 capecitabine [Xeloda]
12 The Efficacy of Penile Rehabilitation Using Udenafil After Total Mesorectal Excision of Rectal Cancer Completed NCT01421940 Phase 4 Placebo drug;Udenafil
13 Intraocular Bevacizumab (Avastin) for Rubeosis Iridis Completed NCT00557232 Phase 4 bevacizumab
14 Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer Completed NCT01912586 Phase 4
15 Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas Recruiting NCT01023984 Phase 4
16 Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia Active, not recruiting NCT02032953 Phase 4 Insulin
17 Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients Active, not recruiting NCT01271582 Phase 4 Irinotecan, 5FU, leucovorin
18 Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil Unknown status NCT00389870 Phase 3 cyclosporine;irinotecan hydrochloride
19 The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer Unknown status NCT01426490 Phase 2, Phase 3
20 Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer Unknown status NCT00749450 Phase 3 capecitabine;fluorouracil;oxaliplatin
21 Early Alimentation Following Colorectal Surgery Unknown status NCT00290524 Phase 3
22 Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC Unknown status NCT01290783 Phase 3 Irintoecan;HA-Irinotecan solution for Infusion
23 The Efficacy of the Caregiver Psychoeducational Consultation Program Unknown status NCT01001884 Phase 2, Phase 3
24 Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer Unknown status NCT00482222 Phase 3 capecitabine;fluorouracil;leucovorin calcium;oxaliplatin
25 Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Unknown status NCT00797485 Phase 3 capecitabine;fluorouracil;irinotecan hydrochloride;leucovorin calcium
26 Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid Unknown status NCT00295646 Phase 3 tamoxifen;anastrozole;zoledronic acid
27 A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer Unknown status NCT00385970 Phase 3 Tegafur-uracil (UFT);Calcium folinate (LV);Krestin (PSK)
28 Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer Unknown status NCT00227747 Phase 3 capecitabine;oxaliplatin
29 Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Unknown status NCT00182715 Phase 3 capecitabine;fluorouracil;leucovorin calcium;oxaliplatin
30 Promoting Physical Activity After Colorectal Cancer Completed NCT00230646 Phase 3
31 Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Completed NCT01607957 Phase 3 TAS-102;Placebo
32 Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery Completed NCT01086618 Phase 2, Phase 3 systemic chemotherapy
33 Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer Completed NCT00252564 Phase 3 Bevacizumab;Oxaliplatin;Leucovorin;Fluorouracil;Cetuximab
34 PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study Completed NCT00115765 Phase 3 Oxaliplatin Based Chemotherapy;Panitumumab;Irinotecan Based Chemotherapy;Bevacizumab
35 A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. Completed NCT00349336 Phase 3 bevacizumab [Avastin];XELOX;bevacizumab [Avastin];FOLFOX-4
36 A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) Completed NCT00152230 Phase 3 UFT (uracil, tegafur)
37 S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 Completed NCT00706121 Phase 3 Vitamin E;Selenium;Vitamin E placebo;selenium placebo
38 Aspirin/Folate Prevention of Large Bowel Polyps Completed NCT00272324 Phase 2, Phase 3 Aspirin;Folate
39 Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity Completed NCT01087658 Phase 3 Glutamine;Calcium and Magnesium
40 Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer Completed NCT00905047 Phase 3 XELODA;TEGAFUR URACIL - FOLINIC ACID
41 A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum. Completed NCT01169558 Phase 3 Bevacizumab;Fluoropyrimidine-based Chemotherapy
42 Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients Completed NCT01030042 Phase 3 FOLFOX-4;Irinotecan/Cetuximab
43 A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer Completed NCT00069108 Phase 3 5 FU;Leucovorin;Oxaliplatin;Oxaliplatin;capecitabine [Xeloda]
44 A Study in Second Line Metastatic Colorectal Cancer Completed NCT01183780 Phase 3 Irinotecan;Folinic Acid;5-Fluorouracil
45 Prevention of Irinotecan Induced Diarrhea by Probiotics Completed NCT01410955 Phase 3
46 XENOX – Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy Completed NCT00272051 Phase 3 SR57746A
47 A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer Completed NCT00009737 Phase 3 5-Fluorouracil;Leucovorin;Capecitabine [Xeloda]
48 Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer Completed NCT00975897 Phase 2, Phase 3 fluorouracil;irinotecan hydrochloride;leucovorin calcium;oxaliplatin
49 Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer Completed NCT00002575 Phase 3
50 Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer Completed NCT00112918 Phase 3 Capecitabine;5-Fluorouracil (5-FU);Leucovorin calcium;Oxaliplatin

Search NIH Clinical Center for Colorectal Cancer 12

Genetic Tests for Colorectal Cancer 12

Genetic tests related to Colorectal Cancer 12:

id Genetic test Affiliating Genes
1 Colorectal Cancer, Susceptibility to, 12 29

Anatomical Context for Colorectal Cancer 12

MalaCards organs/tissues related to Colorectal Cancer 12:

Colon, Liver, Testes, Lung, Prostate, Skin, Kidney

Publications for Colorectal Cancer 12

Variations for Colorectal Cancer 12

UniProtKB/Swiss-Prot genetic disease variations for Colorectal Cancer 12:

id Symbol AA change Variation ID SNP ID
1 POLE p.Val411Leu VAR_069343
2 POLE p.Leu424Val VAR_069344 rs483352909
3 POLE p.Tyr458Phe VAR_077350

ClinVar genetic disease variations for Colorectal Cancer 12:

id Gene Variation Type Significance SNP ID Assembly Location
1 POLE NM_006231.3(POLE): c.1270C> G (p.Leu424Val) single nucleotide variant Pathogenic,risk factor rs483352909 GRCh37 Chromosome 12, 133250250: 133250250
2 POLE NM_006231.3(POLE): c.1420G> A (p.Val474Ile) single nucleotide variant Pathogenic rs980578884 GRCh38 Chromosome 12, 132673217: 132673217

Cosmic variations for Colorectal Cancer 12:

9 (show top 50) (show all 7153)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1 COSM33066 ZZZ3 large intestine,colon,carcinoma,adenocarcinoma c.1366C>T p.P456S 5
2 COSM33067 ZNHIT6 large intestine,colon,carcinoma,adenocarcinoma c.1364T>A p.L455H 5
3 COSM32824 ZNHIT1 large intestine,colon,carcinoma,adenocarcinoma c.400C>T p.R134W 5
4 COSM50818 ZNF813 large intestine,colon,carcinoma,adenocarcinoma c.1636G>A p.G546R 5
5 COSM50466 ZNF536 large intestine,colon,carcinoma,adenocarcinoma c.2533C>G p.L845V 5
6 COSM50465 ZNF536 large intestine,colon,carcinoma,adenocarcinoma c.1158G>T p.W386C 5
7 COSM50281 ZNF521 large intestine,colon,carcinoma,adenocarcinoma c.3524C>T p.T1175M 5
8 COSM50282 ZNF521 large intestine,rectum,carcinoma,adenocarcinoma c.799G>C p.E267Q 5
9 COSM50969 ZNF280D large intestine,colon,carcinoma,adenocarcinoma c.2020A>C p.R674R 5
10 COSM32994 ZNF217 large intestine,colon,carcinoma,adenocarcinoma c.967G>A p.D323N 5
11 COSM32679 ZNF155 large intestine,colon,carcinoma,adenocarcinoma c.1421A>G p.H474R 5
12 COSM50671 ZMIZ2 large intestine,colon,carcinoma,adenocarcinoma c.1850G>A p.R617H 5
13 COSM50768 ZFHX4 large intestine,rectum,carcinoma,adenocarcinoma c.8291C>T p.P2764L 5
14 COSM50764 ZFHX4 large intestine,colon,carcinoma,adenocarcinoma c.681C>A p.F227L 5
15 COSM33074 ZEB2 large intestine,colon,carcinoma,adenocarcinoma c.2947G>A p.D983N 5
16 COSM32424 ZDHHC7 large intestine,colon,carcinoma,adenocarcinoma c.130G>A p.D44N 5
17 COSM32851 ZBTB46 large intestine,colon,carcinoma,adenocarcinoma c.25G>T p.E9* 5
18 COSM33142 YIPF1 large intestine,colon,carcinoma,adenocarcinoma c.475C>T p.R159* 5
19 COSM33161 XRCC1 large intestine,colon,carcinoma,adenocarcinoma c.1048C>T p.R350W 5
20 COSM33194 WRN large intestine,colon,carcinoma,adenocarcinoma c.275G>T p.G92V 5
21 COSM33101 WNT8B large intestine,colon,carcinoma,adenocarcinoma c.157G>C p.E53Q 5
22 COSM32303 WNT16 large intestine,rectum,carcinoma,adenocarcinoma c.376G>A p.V126M 5
23 COSM33107 WNK1 large intestine,colon,carcinoma,adenocarcinoma c.3596A>G p.E1199G 5
24 COSM32899 WAC large intestine,colon,carcinoma,adenocarcinoma c.1424C>T p.S475L 5
25 COSM50645 VWA3B large intestine,colon,carcinoma,adenocarcinoma c.1180C>A p.L394M 5
26 COSM51059 VWA3B large intestine,colon,carcinoma,adenocarcinoma c.312G>T p.L104L 5
27 COSM32407 VWA2 large intestine,colon,carcinoma,adenocarcinoma c.410T>G p.L137R 5
28 COSM32986 VRTN large intestine,colon,carcinoma,adenocarcinoma c.397G>A p.V133M 5
29 COSM32355 VPS13A large intestine,colon,carcinoma,adenocarcinoma c.482G>A p.R161H 5
30 COSM33155 VIM large intestine,colon,carcinoma,adenocarcinoma c.559G>T p.E187* 5
31 COSM17737 VHL large intestine,colon,carcinoma,adenocarcinoma c.314C>T p.T105M 5
32 COSM6444473 VHL large intestine,rectum,carcinoma,adenocarcinoma c.305C>T p.P102L 5
33 COSM6444474 VHL large intestine,rectum,carcinoma,adenocarcinoma c.566A>T p.E189V 5
34 COSM6444471 VHL large intestine,colon,carcinoma,adenocarcinoma c.418C>T p.L140F 5
35 COSM14353 VHL large intestine,colon,carcinoma,adenocarcinoma c.575C>T p.P192L 5
36 COSM3364891 VHL large intestine,colon,carcinoma,adenocarcinoma c.328C>T p.H110Y 5
37 COSM18024 VHL large intestine,colon,carcinoma,adenocarcinoma c.598C>T p.R200W 5
38 COSM6444472 VHL large intestine,colon,carcinoma,adenocarcinoma c.554A>T p.Y185F 5
39 COSM14397 VHL large intestine,colon,carcinoma,adenocarcinoma c.490C>T p.Q164* 5
40 COSM6444475 VHL large intestine,colon,carcinoma,adenocarcinoma c.304C>T p.P102S 5
41 COSM6444470 VHL large intestine,colon,carcinoma,adenocarcinoma c.455C>T p.T152I 5
42 COSM50257 USP32 large intestine,colon,carcinoma,adenocarcinoma c.1283G>A p.G428E 5
43 COSM32422 UQCRC2 large intestine,colon,carcinoma,adenocarcinoma c.176C>G p.S59* 5
44 COSM32283 UQCRC2 large intestine,colon,carcinoma,adenocarcinoma c.623T>A p.F208Y 5
45 COSM33645 UNC79 large intestine,colon,carcinoma,adenocarcinoma c.1-2C>T p.? 5
46 COSM33646 UNC79 large intestine,colon,carcinoma,adenocarcinoma c.3510+2T>C p.? 5
47 COSM53761 UNC79 large intestine,colon,carcinoma,adenocarcinoma c.4495G>A p.V1499I 5
48 COSM33197 UNC13B large intestine,colon,carcinoma,adenocarcinoma c.625C>T p.P209S 5
49 COSM32661 UHRF2 large intestine,colon,carcinoma,adenocarcinoma c.1392+3A>G p.? 5
50 COSM6056917 UGT1A9 large intestine,colon,carcinoma,adenocarcinoma c.1082C>T p.P361L 5

Expression for Colorectal Cancer 12

Search GEO for disease gene expression data for Colorectal Cancer 12.

Pathways for Colorectal Cancer 12

GO Terms for Colorectal Cancer 12

Sources for Colorectal Cancer 12

9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
32 HPO
33 ICD10
34 ICD10 via Orphanet
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
52 Novoseek
55 OMIM via Orphanet
59 PubMed
66 SNOMED-CT via Orphanet
68 Tocris
70 UMLS via Orphanet
Loading form....